Transaminases elevadas em um paciente assintomático: o que fazer?

Marchese, Gabriela Meirelles; Feier, Ana Paula; Jacques, Gabriela; Behling, Jonny Anderson Kielbovicz; Buffon, Leonardo Barres; Silveira, Nathalia Preissler Vaz; Silveira, Victoria D'azevedo; Kupski, Carlos.
Acta méd. (Porto Alegre) ; 39(1): 141-154, 2018.
Artigo em Português | LILACS | ID: biblio-910586

Documentos relacionados

  1. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial.
  2. Evaluation of the Diagnostic Potential of Liver Aminotransferases and Alkaline Phosphatase in Patients with Cardiovascular Diseases.
  3. Aminotransferases as causal factors for metabolic syndrome: A bidirectional Mendelian randomization study.
  4. Reference intervals of 14 biochemical markers for children and adolescence in China: the PRINCE study.
  5. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.
  6. Prolonged abnormal isolated aminotransferase levels in healthy children is a benign condition.
  7. Biomarkers of liver diseases.
  8. Elevated serum PAR-1 levels as an emerging biomarker of inflammation to predict the dengue infection severity.
  9. Role of derived neutrophil-to-lymphocyte ratio, uric acid-to-creatinine ratio and Delta neutrophil index for predicting neonatal outcomes in pregnancies with preeclampsia.
  10. Structured Early detection of Asymptomatic Liver Cirrhosis: Results of the population-based liver screening program SEAL.